[HTML][HTML] Innovations and development of COVID-19 vaccines: A patent review
More than 125 million confirmed cases of COVID-19 have been reported globally with rising
cases in all countries since the first case was reported. A vaccine is the best measure for the …
cases in all countries since the first case was reported. A vaccine is the best measure for the …
The importance of RNA-based vaccines in the fight against COVID-19: an overview
In recent years, vaccine development using ribonucleic acid (RNA) has become the most
promising and studied approach to produce safe and effective new vaccines, not only for …
promising and studied approach to produce safe and effective new vaccines, not only for …
Could nanotechnology help to end the fight against COVID-19? Review of current findings, challenges and future perspectives
AT Yayehrad, EA Siraj, GB Wondie… - International Journal …, 2021 - Taylor & Francis
A serious viral infectious disease was introduced to the globe by the end of 2019 that was
seen primarily from China, but spread worldwide in a few months to be a pandemic. Since …
seen primarily from China, but spread worldwide in a few months to be a pandemic. Since …
[PDF][PDF] Skating the line between general wellness products and regulated devices: strategies and implications
Health technology is advancing at a rapid clip, with many of these technologies appearing
on consumer products like smartphones and tablets. Federal regulators have responded to …
on consumer products like smartphones and tablets. Federal regulators have responded to …
Minimum infective dose of severe acute respiratory syndrome coronavirus 2 based on the current evidence: a systematic review
Objective: Understanding the minimum infective dose is significant for risk assessment in the
performance of suitable infection control strategies in healthcare centers. However, the …
performance of suitable infection control strategies in healthcare centers. However, the …
[PDF][PDF] Mascarenhas
BAS Machado, KVS Hodel, L Fonseca - Prostate, 2021 - academia.edu
In recent years, vaccine development using ribonucleic acid (RNA) has become the most
promising and studied approach to produce safe and effective new vaccines, not only for …
promising and studied approach to produce safe and effective new vaccines, not only for …
Synthesis, characterization of new heterocyclic compound: pyrazolyl hydrazino quinoxaline derivative: 3-[5-(hydroxy1methyl)-1-phenylpyrazol-3-yl]-2-[2, 4, 5 …
ER Sallam, SF Aboulnaga, AM Samy… - Journal of Molecular …, 2023 - Elsevier
Pyrazole and quinoxaline synthesis is gaining popularity due to its wide range of
pharmacological qualities, including antiviral, antagonist, antibacterial, anticancer, anti …
pharmacological qualities, including antiviral, antagonist, antibacterial, anticancer, anti …
Patent intelligence of RNA viruses: Implications for combating emerging and re-emerging RNA virus based infectious diseases
The recent outbreak of one of the RNA viruses (2019-nCoV) has affected most of the
population and the fatalities reported may label it as a modern-day scourge. Active research …
population and the fatalities reported may label it as a modern-day scourge. Active research …
The global patent landscape of emerging infectious disease monkeypox
Y Cai, X Zhang, K Zhang, J Liang, P Wang… - BMC Infectious …, 2024 - Springer
Background Monkeypox is an emerging infectious disease with confirmed cases and deaths
in several parts of the world. In light of this crisis, this study aims to analyze the global …
in several parts of the world. In light of this crisis, this study aims to analyze the global …
Patent landscape of COVID-19 innovations: A comprehensive review
The COVID 19 pandemic gave a stringent upshot on the lives of human. The people are
running in race to save themselves and the race is still on. Covid emergency has not only …
running in race to save themselves and the race is still on. Covid emergency has not only …